A Randomized, Double Blind, Placebo-Controlled, Multicenter, 18 week Pilto Study to Investigate the Neuroprotective Effect pg Procrit on the Development of Peripheral Neuropathy in Patients Receiving Chemotherapy for Advanced Ovarian Cancer

Grants and Contracts Details

StatusFinished
Effective start/end date11/1/0610/31/09

Funding

  • Ortho Biotech Inc: $3,000.00